Minocycline prevents paraquat-induced cell death through attenuating endoplasmic reticulum stress and mitochondrial dysfunction

Toxicology Letters

Volumn 209, Issue 3, 2012, Pages 203-210

  Huang, Chuen Lin ^a,b   Lee, Yi Chao ^c   Yang, Ying Chen ^d   Kuo, Tsun Yung ^d   Huang, Nai Kuei ^e,f  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL ILAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Endoplasmic reticulum stress; Minocycline; Mitochondrial dysfunction; Paraquat

Indexed keywords

CASPASE 12; CASPASE 3; LIPOCORTIN 5; MINOCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARAQUAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME RELEASE; INFRARED SPECTROSCOPY; MITOCHONDRIAL DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; UNFOLDED PROTEIN RESPONSE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 12; CELL DEATH; CELL SURVIVAL; ENDOPLASMIC RETICULUM; HERBICIDES; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MINOCYCLINE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; PARAQUAT; PC12 CELLS; PERMEABILITY; RATS; REACTIVE OXYGEN SPECIES;

EID: 84862801102     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.12.021     Document Type: Article

References (55)

1. Abeliovich A., Flint Beal M. Parkinsonism genes: culprits and clues. J. Neurochem. 2006, 99:1062-1072.
2. 2+-dependent ion channels. J. Bioenerg. Biomembr. 2010, 42:151-163.
3. Baldereschi M., Di Carlo A., Vanni P., Ghetti A., Carbonin P., Amaducci L., Inzitari D. Lifestyle-related risk factors for Parkinson's disease: a population-based study. Acta Neurol. Scand. 2003, 108:239-244.
4. Berry C., La Vecchia C., Nicotera P. Paraquat and Parkinson's disease. Cell Death Differ. 2010, 17:1115-1125.
5. Bonilla E., Medina-Leendertz S., Villalobos V., Molero L., Bohorquez A. Paraquat-induced oxidative stress in Drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid. Neurochem. Res. 2006, 31:1425-1432.
6. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
7. Brown T.P., Rumsby P.C., Capleton A.C., Rushton L., Levy L.S. Pesticides and Parkinson's disease - is there a link?. Environ. Health Perspect. 2006, 114:156-164.
8. Castello P.R., Drechsel D.A., Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 2007, 282:14186-14193.
9. Chinta S.J., Rane A., Poksay K.S., Bredesen D.E., Andersen J.K., Rao R.V. Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquat. Neuromol. Med. 2008, 10:333-342.
10. Chung Y.C., Ko H.W., Bok E., Park E.S., Huh S.H., Nam J.H., Jin B.K. The role of neuroinflammation on the pathogenesis of Parkinson's disease. BMB Rep. 2010, 43:225-232.
11. Cocheme H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J. Biol. Chem. 2008, 283:1786-1798.
12. Costantini P., Petronilli V., Colonna R., Bernardi P. On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. Toxicology 1995, 99:77-88.
13. Diguet E., Gross C.E., Tison F., Bezard E. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp. Neurol. 2004, 189:1-4.
14. Domercq M., Matute C. Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 2004, 25:609-612.
15. Dorn G.W., Scorrano L. Two close, too close: sarcoplasmic reticulum-mitochondrial crosstalk and cardiomyocyte fate. Circ. Res. 2010, 107:689-699.
16. Drechsel D.A., Patel M. Chapter 21 Paraquat-induced production of reactive oxygen species in brain mitochondria. Methods Enzymol. 2009, 456:381-393.
17. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:14669-14674.
18. Elewa H.F., Hilali H., Hess D.C., Machado L.S., Fagan S.C. Minocycline for short-term neuroprotection. Pharmacotherapy 2006, 26:515-521.
19. Gonzalez-Polo R.A., Rodriguez-Martin A., Moran J.M., Niso M., Soler G., Fuentes J.M. Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res. 2004, 1011:170-176.
20. Grenier D., Huot M.P., Mayrand D. Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics. Antimicrob. Agents Chemother. 2000, 44:763-766.
21. Grimm S., Brdiczka D. The permeability transition pore in cell death. Apoptosis 2007, 12:841-855.
22. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection. Lancet Neurol. 2009, 8:382-397.
23. Huang N.K., Lin Y.W., Huang C.L., Messing R.O., Chern Y. Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J. Biol. Chem. 2001, 276:13838-13846.
24. Kang X., Chen J., Xu Z., Li H., Wang B. Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells. Toxicol. In Vitro 2007, 21:1003-1009.
25. Kim H.S., Suh Y.H. Minocycline and neurodegenerative diseases. Behav. Brain Res. 2009, 196:168-179.
26. Kinnally K.W., Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 2007, 12:857-868.
27. Kraus R.L., Pasieczny R., Lariosa-Willingham K., Turner M.S., Jiang A., Trauger J.W. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J. Neurochem. 2005, 94:819-827.
28. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
29. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., Shokat K.M., Lavail M.M., Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318:944-949.
30. LoPachin R.M., Gavin T. Response to Paraquat: the red herring of Parkinson's disease research. Toxicol. Sci. 2008, 103:219-221. author reply 222-213.
31. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003, 8:115-128.
32. Malhotra J.D., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxid. Redox Signal. 2007, 9:2277-2293.
33. Malhotra J.D., Kaufman R.J. ER stress and its functional link to mitochondria: role in cell survival and death. Cold Spring Harb. Perspect Biol. 2011, 3:a004424.
34. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 2003, 23:3095-3099.
35. Martinez T.N., Greenamyre J.T. Toxin models of mitochondrial dysfunction in Parkinson's disease. Antioxid. Redox Signal. 2011, (Epub ahead of print).
36. Miller G.W. Paraquat: the red herring of Parkinson's disease research. Toxicol. Sci. 2007, 100:1-2.
37. Mortiboys H., Johansen K.K., Aasly J.O., Bandmann O. Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 2010, 75:2017-2020.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
39. Nedergaard J., Cannon B. Overview - preparation and properties of mitochondria from different sources. Methods Enzymol. 1979, 55:3-28.
40. Nussbaum R.L., Ellis C.E. Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 2003, 348:1356-1364.
41. Park J.S., Mehta P., Cooper A.A., Veivers D., Heimbach A., Stiller B., Kubisch C., Fung V.S., Krainc D., Mackay-Sim A., Sue C.M. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Hum. Mutat. 2011, 32:956-964.
42. Peng J., Peng L., Stevenson F.F., Doctrow S.R., Andersen J.K. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J. Neurosci. 2007, 27:6914-6922.
43. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 1999, 76:725-734.
44. Plane J.M., Shen Y., Pleasure D.E., Deng W. Prospects for minocycline neuroprotection. Arch. Neurol. 2010, 67:1442-1448.
45. Purisai M.G., McCormack A.L., Cumine S., Li J., Isla M.Z., Di Monte D.A. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol. Dis. 2007, 25:392-400.
46. Ramachandiran S., Hansen J.M., Jones D.P., Richardson J.R., Miller G.W. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol. Sci. 2007, 95:163-171.
47. Repetto G., del Peso A., Zurita J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 2008, 3:1125-1131.
48. Ryu S.Y., Peixoto P.M., Teijido O., Dejean L.M., Kinnally K.W. Role of mitochondrial ion channels in cell death. Biofactors 2010, 36:255-263.
49. Shimada H., Hirai K., Simamura E., Hatta T., Iwakiri H., Mizuki K., Sawasaki T., Matsunaga S., Endo Y., Shimizu S. Paraquat toxicity induced by voltage-dependent anion channel 1 acts as an NADH-dependent oxidoreductase. J. Biol. Chem. 2009, 284:28642-28649.
50. Tanner C.M. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 1989, 12:49-54.
51. Tanner C.M., Kamel F., Ross G.W., Hoppin J.A., Goldman S.M., Korell M., Marras C., Bhudhikanok G.S., Kasten M., Chade A.R., Comyns K., Richards M.B., Meng C., Priestley B., Fernandez H.H., Cambi F., Umbach D.M., Blair A., Sandler D.P., Langston J.W. Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 2011, 119:866-872.
52. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. JAMA 1999, 281:341-346.
53. Wirdefeldt K., Gatz M., Schalling M., Pedersen N.L. No evidence for heritability of Parkinson disease in Swedish twins. Neurology 2004, 63:305-311.
54. Yang W., Tiffany-Castiglioni E., Koh H.C., Son I.H. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol. Lett. 2009, 191:203-210.
55. Zhang K., Kaufman R.J. Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb. Exp. Pharmacol. 2006, 69-91.